北美生物防御市场到 2027 年 - 北美生物防御市场到 2027 年的区域分析和预测 - 按产品(炭疽、天花、肉毒杆菌、辐射/核、其他)进行区域分析和预测;和国家

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 134    |    Report Code: TIPRE00009997    |    Category: Life Sciences

North America Biodefense Market

北美生物防御市场预计将从 2019 年的 15.6929 亿美元增至 2027 年的 33.5783 亿美元。该市场预计将以 10.1% 的复合年增长率增长2020-2027。

生物防御市场的增长主要是由于有利的政府举措的存在以及自然发生的疫情数量的增加。生物防御组织的影响范围有限等限制因素可能会损害未来几年市场的增长。另一方面,技术的不断采用预计将对未来几年北美生物防御市场的增长产生积极影响。

<疾病暴发通常由感染引起,通过人与人之间、动物与人之间的接触、或者从环境或其他介质传播。新发传染病是最近在人群中出现并且正在迅速增加或有可能很快增加的感染。世界卫生组织在 2007 年的报告中警告说,传染病正在以前所未有的速度出现。自 20 世纪 70 年代以来,已发现约 40 种传染病,包括 SARS、MERS、埃博拉、禽流感、猪流感、寨卡病毒以及最近的冠状病毒。此外,据美国疾病控制与预防中心估计,2016年至2017年间,美国有近3000万人感染流感。有助于将患病率减少 17%,就诊次数和住院次数分别减少 18% 至 19%。埃博拉和寨卡病毒感染的日益流行也可能有助于市场的发展。例如,由于冠状病毒的爆发,截至 2020 年 3 月 20 日,已向世界卫生组织报告了超过 21 万例病例,超过 9,000 人丧生。此外,2020 年 3 月 18 日,Emergent BioSolutions 与 Vaxart 签署了开发和制造协议用于冠状病毒疾病的实验性口服候选疫苗。

炭疽或天花等病原体、生物毒素、化学武器等的释放神经毒气或放射性物质过去曾造成公众威胁。为了防止此类疫情的爆发,政府制定了各种策略,例如,美国国立卫生研究院支持传染病和生物防御研究,建立并维护有关传染病和免疫相关疾病的基础知识基础,并利用这些知识开发新的和改进诊断、治疗和预防措施,包括疫苗。

冠状病毒埃博拉和寨卡病毒等传染病的日益流行可能会增加该领域的投资

 

2019年,美国占据北美生物防御市场最大的市场份额,预计在预测期内将以更快的速度增长。美国是一个经济发达国家,该国在生物技术市场上拥有众多成熟的参与者。美国军事和民事机构为生物防御提供的大量资金也是该地区收入份额最高的关键因素之一。因此,考虑到上述因素,预计美国生物防御市场在预测期内将大幅增长。

 

< strong>到 2027 年美国生物防御市场收入和预测(百万美元)


 

北美透明矫正器 -市场细分

按产品

  • 炭疽
  • 天花
  • 肉毒中毒
  • 辐射/核< /li>
  • 其他

按地理位置

  • 北美
    • 美国
    • 加拿大
    • 墨西哥

公司简介

  • < span>巴伐利亚北欧
  • Alnylam Pharmaceuticals, Inc.
  • SIGA Technologies
  • Emergent BioSolutions Inc.
  • 克利夫兰生物实验室
  • Dynavax Technologies
  • Elusys Therapeutics, Inc.
  • Soligenix
  • Altimmune
  • Pluristem 疗法。


North America Biodefense Strategic Insights

Strategic insights for North America Biodefense involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-biodefense-market-strategic-framework.webp
Get more information on this report

North America Biodefense Report Scope

Report Attribute Details
Market size in 2019 US$ 1,569.29 Million
Market Size by 2027 US$ 3,357.83 Million
Global CAGR (2020 - 2027) 10.1%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 产品
  • 炭疽
  • 天花
  • 肉毒杆菌
  • 辐射/æ ¸
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Bavarian Nordic
  • Alnylam Pharmaceuticals, Inc.
  • SIGA Technologies
  • Emergent BioSolutions Inc.
  • Cleveland Bio Labs
  • Dynavax Technologies
  • Elusys Therapeutics, Inc.
  • Soligenix
  • Altimmune
  • Pluristem Therapeutics
  • Get more information on this report

    North America Biodefense Regional Insights

    The regional scope of North America Biodefense refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-biodefense-market-geography.webp
    Get more information on this report

    The List of Companies - North America Biodefense Market

    The List of Companies - North America Biodefense Market

    1. Bavarian Nordic
    2. Alnylam Pharmaceuticals, Inc.
    3. SIGA Technologies
    4. Emergent BioSolutions Inc.
    5. Cleveland Bio Labs
    6. Dynavax Technologies
    7. Elusys Therapeutics, Inc.
    8. Soligenix
    9. Altimmune
    10. Pluristem Therapeutics

     

    Frequently Asked Questions
    How big is the North America Biodefense Market?

    The North America Biodefense Market is valued at US$ 1,569.29 Million in 2019, it is projected to reach US$ 3,357.83 Million by 2027.

    What is the CAGR for North America Biodefense Market by (2020 - 2027)?

    As per our report North America Biodefense Market, the market size is valued at US$ 1,569.29 Million in 2019, projecting it to reach US$ 3,357.83 Million by 2027. This translates to a CAGR of approximately 10.1% during the forecast period.

    What segments are covered in this report?

    The North America Biodefense Market report typically cover these key segments-

  • 产品 (炭疽, 天花, 肉毒杆菌, 辐射/核)
  • What is the historic period, base year, and forecast period taken for North America Biodefense Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Biodefense Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in North America Biodefense Market?

    The North America Biodefense Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bavarian Nordic
  • Alnylam Pharmaceuticals, Inc.
  • SIGA Technologies
  • Emergent BioSolutions Inc.
  • Cleveland Bio Labs
  • Dynavax Technologies
  • Elusys Therapeutics, Inc.
  • Soligenix
  • Altimmune
  • Pluristem Therapeutics
  • Who should buy this report?

    The North America Biodefense Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Biodefense Market value chain can benefit from the information contained in a comprehensive market report.